National Cancer Center Inc
National Cancer Center Inc shows consistent revenue growth and asset accumulation with no reported officer compensation.
EIN: 131919715 · West Islip, NY · NTEE: G30Z · Updated: 2026-03-28
About National Cancer Center Inc
National Cancer Center Inc (EIN: 131919715) is a nonprofit organization based in West Islip, NY, classified under NTEE code G30Z. The organization reported total revenue of $3.6M and total assets of $1.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of National Cancer Center Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates National Cancer Center Inc with a Mission Score of 75 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 75%
- fundraising: 10%
According to IRS 990 filings, National Cancer Center Inc allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, which is unusual for an organization with annual revenues exceeding $3 million. This suggests either a fully volunteer executive leadership or that compensation for key management is reported under different categories, warranting further scrutiny for complete transparency.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of National Cancer Center Inc's IRS 990 filings:
- Consistent 0% officer compensation reported, which may obscure actual executive remuneration if compensated through other means.
- Lack of detailed expense breakdown (program, admin, fundraising) in provided data, hindering a full efficiency assessment.
Strengths
The following positive indicators were identified for National Cancer Center Inc:
- Consistent revenue generation, with latest revenue at $3,605,404.
- Steady growth in assets, from $1,562,089 in 201403 to $3,829,399 in 202303, indicating financial stability.
- Generally positive net income (revenue exceeding expenses) across most years, demonstrating sound financial management.
Frequently Asked Questions about National Cancer Center Inc
How does National Cancer Center Inc compensate its executive leadership if officer compensation is consistently reported as 0%?
The provided data consistently shows 0% officer compensation across all filings. This could mean executive leadership is entirely volunteer-based, or their compensation is categorized differently within the financial statements, which would require a deeper dive into the full IRS 990 forms to ascertain.
What is the detailed breakdown of program, administrative, and fundraising expenses?
The provided summary data does not offer a detailed breakdown of expenses into program, administrative, and fundraising categories. A full IRS 990 filing would be necessary to determine these specific percentages and assess spending efficiency.
What specific programs does National Cancer Center Inc fund with its revenue?
The provided financial data does not detail the specific programs or initiatives funded by the National Cancer Center Inc. This information would typically be found in the organization's mission statement and program service accomplishments section of its IRS 990.
Filing History
IRS 990 filing history for National Cancer Center Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), National Cancer Center Inc's revenue has grown by 120.2%, moving from $2.1M to $4.6M. Total assets increased by 310% over the same period, from $934K to $3.8M. Total functional expenses rose by 121.3%, from $2.0M to $4.5M. In its most recent filing year (2023), National Cancer Center Inc reported a surplus of $27K, with revenue exceeding expenses. The organization holds $1.1M in liabilities against $3.8M in assets (debt-to-asset ratio: 28.0%), resulting in net assets of $2.8M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. | |
|---|---|---|---|---|---|---|
| 2023 | $4.6M | $4.5M | $3.8M | $1.1M | — | View 990 |
| 2022 | $4.6M | $4.5M | $3.8M | $830K | — | View 990 |
| 2021 | $5.7M | $4.8M | $4.0M | $1.1M | — | View 990 |
| 2020 | $4.7M | $4.2M | $2.8M | $877K | — | View 990 |
| 2019 | $4.2M | $3.6M | $2.1M | $734K | — | View 990 |
| 2018 | $3.3M | $3.2M | $1.7M | $845K | — | View 990 |
| 2017 | $3.2M | $2.8M | $1.6M | $457K | — | View 990 |
| 2016 | $2.5M | $2.4M | $1.1M | $345K | — | View 990 |
| 2015 | $2.7M | $2.8M | $1.5M | $894K | — | View 990 |
| 2014 | $2.9M | $2.9M | $1.6M | $782K | — | View 990 |
| 2013 | $3.4M | $3.3M | $1.9M | $1.1M | — | View 990 |
| 2012 | $2.7M | $5.2M | $1.4M | $788K | — | View 990 |
| 2011 | $2.1M | $2.0M | $934K | $474K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $4.6M, expenses of $4.5M, and assets of $3.8M (revenue -0.5% year-over-year).
- 2022: Revenue of $4.6M, expenses of $4.5M, and assets of $3.8M (revenue -20.0% year-over-year).
- 2021: Revenue of $5.7M, expenses of $4.8M, and assets of $4.0M (revenue +20.7% year-over-year).
- 2020: Revenue of $4.7M, expenses of $4.2M, and assets of $2.8M (revenue +14.1% year-over-year).
- 2019: Revenue of $4.2M, expenses of $3.6M, and assets of $2.1M (revenue +27.0% year-over-year).
- 2018: Revenue of $3.3M, expenses of $3.2M, and assets of $1.7M (revenue +3.4% year-over-year).
- 2017: Revenue of $3.2M, expenses of $2.8M, and assets of $1.6M (revenue +27.6% year-over-year).
- 2016: Revenue of $2.5M, expenses of $2.4M, and assets of $1.1M (revenue -7.9% year-over-year).
- 2015: Revenue of $2.7M, expenses of $2.8M, and assets of $1.5M (revenue -8.4% year-over-year).
- 2014: Revenue of $2.9M, expenses of $2.9M, and assets of $1.6M (revenue -14.4% year-over-year).
- 2013: Revenue of $3.4M, expenses of $3.3M, and assets of $1.9M (revenue +25.4% year-over-year).
- 2012: Revenue of $2.7M, expenses of $5.2M, and assets of $1.4M (revenue +32.4% year-over-year).
- 2011: Revenue of $2.1M, expenses of $2.0M, and assets of $934K.
Data Sources and Methodology
This transparency report for National Cancer Center Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.